Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …

Introduction The risk of cardiovascular disease (CVD) and atherosclerosis is reported to be
increased in systemic lupus erythematosus (SLE). We recently reported a negative …

Atherosclerosis is an inflammatory disease, and the major cause of cardiovascular disease
(CVD). This notion is based on the presence of immune-competent cells in atherosclerotic …

Objective To examine how treatment of rheumatoid arthritis (RA) with anti-tumour necrosis
factor alpha antagonists (anti-TNF) and B-cell targeting rituximab influences novel markers …

Introduction Patients with rheumatoid arthritis (RA) have an increased risk for cardiovascular
disease (CVD) independent of traditional risk factors. The aim of this study was to analyze …

Atherosclerosis shares many similarities with inflammatory and autoimmune diseases,
among them rheumatoid arthritis (RA). Anticardiolipin antibodies (aCL) and antibodies …

Introduction Diagnosis of antiphospholipid syndrome (APS) still remains a laboratory
challenge due to the great diversity of antiphospholipid antibodies (aPL) and their …

Clinical importance of the antiphospholipid antibody syndrome (APS). APS is a condition in
which clinical features such as vascular thromboses, recurrent fetal loss, and …

Background The effect of antiphospholipid antibodies (aPL) on organ damage in Systemic
Lupus Erythematosus (SLE) patients remains unclear as there is a limited number of studies …

Background The presence of autoantibodies is considered an important characteristic of
rheumatoid arthritis (RA); therefore, both anticitrullinated protein antibodies (ACPA) and …